Follows joint letter calling for pharmacists to be able make minor prescription changes

Bispecific antibody targets EGFR and MET mutated tumours

LYT-100 will be evaluated in patients with persistent symptoms caused by COVID-19

Updated Date: Fri, 27 Nov 2020 00:00:00 EST

Updated Date: Fri, 27 Nov 2020 00:00:00 EST

Updated Date: Fri, 27 Nov 2020 00:00:00 EST

Updated Date: Fri, 27 Nov 2020 00:00:00 EST

Treatment of SARS-CoV-2 infection with a new antiviral drug, MK-4482/EIDD-2801 or Molnupiravir, completely suppresses virus transmission within 24 […]

Scientists used human white blood cell membranes to carry two drugs, an antibiotic and an anti-inflammatory, directly to […]

Researchers from Skoltech and the University of Texas at Austin have presented a proof-of-concept for a wearable sensor […]